PhD and Postdoc Positions in RNA Therapeutics, Vascular Inflammation, Ageing, and Angiometabolic Disease at Universitätsmedizin Mannheim Universitätsmedizin Mannheim in Germany

Universitätsmedizin Mannheim at Heidelberg University is expanding its clinical and translational angiometabolic medicine program in the VI. Medizinische Klinik (Angiology & Diabetology). The post announces a growing academic and clinical environment focused on modern vascular medicine, interdisciplinary patient care, and translational research.

Research openings are expected soon for PhD, Postdoc, and Senior Scientist roles. The stated research themes include RNA therapeutics, vascular inflammation, ageing, and angiometabolic disease. The broader program connects bedside care with mechanistic discovery and innovation, making it relevant for candidates interested in translational medicine, vascular biology, and disease-oriented research.

The announcer is Professor Konstantinos Stellos, Director of the VI. Medizinische Klinik and Chair of Medicine, affiliated with Heidelberg University and Universitätsmedizin Mannheim. The post also references the Heidelberg–Mannheim university network and related clinical/research partners.

In addition to the research track, the clinic is advertising clinical openings ranging from residency training to senior consultant and leadership roles in angiology, interventional vascular medicine, diabetology, endocrinology, wound healing, and clinical study coordination. The linked Mannheim clinic page lists positions such as Oberarzt, Fach-/Assistenzarzt, Physician Assistant, and leadership roles in vascular outpatient care and wound healing.

No specific deadline, stipend, tuition, or funding package is stated in the post excerpt. Interested applicants should follow the linked university hospital and LinkedIn announcements for the formal vacancy details and application instructions once the research positions are posted.